Pfizer, BioNtech submit data to FDA for Covid-19 vaccine booster authorisation
The data will also be submitted to the European Medicines Agency (EMA) and other regulatory authorities in the coming weeks, the drugmakers said
Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer Inc and German partner BioNtech SE have submitted initial data from an early stage trial to support application seeking authorisation of a booster dose of their Covid-19 vaccine, the drugmakers said on Monday.
The data will also be submitted to the European Medicines Agency (EMA) and other regulatory authorities in the coming weeks, the drugmakers said.
Keep updated, follow The Business Standard's Google news channel
